Annual Cash & Cash Equivalents
$5.44 M
-$21.61 M-79.90%
31 December 2023
Summary:
AIM ImmunoTech annual cash & cash equivalents is currently $5.44 million, with the most recent change of -$21.61 million (-79.90%) on 31 December 2023. During the last 3 years, it has fallen by -$26.65 million (-83.05%). AIM annual cash & cash equivalents is now -90.63% below its all-time high of $58.07 million, reached on 31 December 2009.AIM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$915.00 K
-$2.64 M-74.25%
30 September 2024
Summary:
AIM ImmunoTech quarterly cash and cash equivalents is currently $915.00 thousand, with the most recent change of -$2.64 million (-74.25%) on 30 September 2024. Over the past year, it has dropped by -$4.52 million (-83.18%). AIM quarterly cash and cash equivalents is now -98.50% below its all-time high of $61.04 million, reached on 30 September 2009.AIM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AIM Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -83.2% |
| 3 y3 years | -83.0% | -97.2% |
| 5 y5 years | +270.0% | -37.8% |
AIM Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -83.0% | at low | -97.3% | at low |
| 5 y | 5 years | -85.9% | +270.0% | -98.1% | at low |
| alltime | all time | -90.6% | +1719.1% | -98.5% | +206.0% |
AIM ImmunoTech Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $915.00 K(-74.3%) |
| June 2024 | - | $3.55 M(+7.9%) |
| Mar 2024 | - | $3.29 M(-39.4%) |
| Dec 2023 | $5.44 M(-79.9%) | $5.44 M(-64.4%) |
| Sept 2023 | - | $15.26 M(-27.4%) |
| June 2023 | - | $21.04 M(-10.1%) |
| Mar 2023 | - | $23.39 M(-13.5%) |
| Dec 2022 | $27.05 M(-15.7%) | $27.05 M(-9.1%) |
| Sept 2022 | - | $29.76 M(-13.6%) |
| June 2022 | - | $34.45 M(+18.8%) |
| Mar 2022 | - | $28.99 M(-9.7%) |
| Dec 2021 | $32.09 M(-16.6%) | $32.09 M(-14.1%) |
| Sept 2021 | - | $37.35 M(-9.2%) |
| June 2021 | - | $41.14 M(-15.6%) |
| Mar 2021 | - | $48.77 M(+26.7%) |
| Dec 2020 | $38.50 M(+2519.1%) | $38.50 M(+0.0%) |
| Sept 2020 | - | $38.50 M(+13.5%) |
| June 2020 | - | $33.91 M(+22.9%) |
| Mar 2020 | - | $27.59 M(+1776.9%) |
| Dec 2019 | $1.47 M(+391.6%) | $1.47 M(-84.7%) |
| Sept 2019 | - | $9.62 M(+902.7%) |
| June 2019 | - | $959.00 K(-59.9%) |
| Mar 2019 | - | $2.39 M(+700.7%) |
| Dec 2018 | $299.00 K(-78.8%) | $299.00 K(-92.6%) |
| Sept 2018 | - | $4.05 M(+13.6%) |
| June 2018 | - | $3.57 M(-9.8%) |
| Mar 2018 | - | $3.96 M(+180.2%) |
| Dec 2017 | $1.41 M(-41.4%) | $1.41 M(+180.7%) |
| Sept 2017 | - | $503.00 K(-58.8%) |
| June 2017 | - | $1.22 M(+57.5%) |
| Mar 2017 | - | $776.00 K(-67.8%) |
| Dec 2016 | $2.41 M(+13.9%) | $2.41 M(-46.2%) |
| Sept 2016 | - | $4.47 M(+190.8%) |
| June 2016 | - | $1.54 M(+51.8%) |
| Mar 2016 | - | $1.01 M(-52.1%) |
| Dec 2015 | $2.12 M(-1.9%) | $2.12 M(+82.2%) |
| Sept 2015 | - | $1.16 M(-37.0%) |
| June 2015 | - | $1.84 M(-37.4%) |
| Mar 2015 | - | $2.94 M(+36.5%) |
| Dec 2014 | $2.16 M(+168.5%) | $2.16 M(+70.8%) |
| Sept 2014 | - | $1.26 M(-51.8%) |
| June 2014 | - | $2.62 M(-36.2%) |
| Mar 2014 | - | $4.11 M(+411.2%) |
| Dec 2013 | $803.00 K(-63.7%) | $803.00 K(-49.7%) |
| Sept 2013 | - | $1.60 M(+22.4%) |
| June 2013 | - | $1.31 M(-17.8%) |
| Mar 2013 | - | $1.59 M(-28.2%) |
| Dec 2012 | $2.21 M(-28.7%) | $2.21 M(-30.0%) |
| Sept 2012 | - | $3.16 M(+45.5%) |
| June 2012 | - | $2.17 M(-40.5%) |
| Mar 2012 | - | $3.65 M(+17.6%) |
| Dec 2011 | $3.10 M(+6.3%) | $3.10 M(-22.8%) |
| Sept 2011 | - | $4.02 M(+93.4%) |
| June 2011 | - | $2.08 M(-28.8%) |
| Mar 2011 | - | $2.92 M(0.0%) |
| Dec 2010 | $2.92 M | $2.92 M(-4.1%) |
| Sept 2010 | - | $3.04 M(-42.9%) |
| June 2010 | - | $5.33 M(-89.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $50.72 M(-12.7%) |
| Dec 2009 | $58.07 M(+849.0%) | $58.07 M(-4.9%) |
| Sept 2009 | - | $61.04 M(+50.1%) |
| June 2009 | - | $40.66 M(+1022.8%) |
| Mar 2009 | - | $3.62 M(-40.8%) |
| Dec 2008 | $6.12 M(-46.7%) | $6.12 M(-19.4%) |
| Sept 2008 | - | $7.59 M(-25.1%) |
| June 2008 | - | $10.14 M(+5.2%) |
| Mar 2008 | - | $9.64 M(-15.9%) |
| Dec 2007 | $11.47 M(+214.6%) | $11.47 M(+74.8%) |
| Sept 2007 | - | $6.56 M(-6.1%) |
| June 2007 | - | $6.99 M(+67.2%) |
| Mar 2007 | - | $4.18 M(+14.6%) |
| Dec 2006 | $3.65 M(-4.7%) | $3.65 M(-19.3%) |
| Sept 2006 | - | $4.52 M(+76.8%) |
| June 2006 | - | $2.56 M(-75.7%) |
| Mar 2006 | - | $10.52 M(+174.9%) |
| Dec 2005 | $3.83 M(-56.6%) | $3.83 M(-22.9%) |
| Sept 2005 | - | $4.97 M(-14.4%) |
| June 2005 | - | $5.80 M(-13.3%) |
| Mar 2005 | - | $6.69 M(-24.1%) |
| Dec 2004 | $8.81 M(+134.1%) | $8.81 M(-31.2%) |
| Sept 2004 | - | $12.80 M(+186.9%) |
| June 2004 | - | $4.46 M(+37.4%) |
| Mar 2004 | - | $3.25 M(-13.7%) |
| Dec 2003 | $3.76 M(+66.8%) | $3.76 M(-25.6%) |
| Sept 2003 | - | $5.06 M(+8.6%) |
| June 2003 | - | $4.66 M(+36.7%) |
| Mar 2003 | - | $3.41 M(+51.1%) |
| Dec 2002 | $2.26 M(-27.4%) | $2.26 M(-35.0%) |
| Sept 2002 | - | $3.47 M(+5.2%) |
| June 2002 | - | $3.30 M(-5.0%) |
| Mar 2002 | - | $3.47 M(+11.8%) |
| Dec 2001 | $3.11 M(-16.5%) | $3.11 M(+8.7%) |
| Sept 2001 | - | $2.86 M(+10.6%) |
| June 2001 | - | $2.58 M(+25.7%) |
| Mar 2001 | - | $2.06 M(-44.7%) |
| Dec 2000 | $3.72 M(-41.9%) | $3.72 M(-46.1%) |
| Sept 2000 | - | $6.90 M(-16.4%) |
| June 2000 | - | $8.25 M(-16.6%) |
| Mar 2000 | - | $9.89 M(+54.6%) |
| Dec 1999 | $6.40 M(-46.7%) | $6.40 M(-5.9%) |
| Sept 1999 | - | $6.80 M(-25.3%) |
| June 1999 | - | $9.10 M(-13.3%) |
| Mar 1999 | - | $10.50 M(-12.5%) |
| Dec 1998 | $12.00 M(+33.3%) | $12.00 M(-16.1%) |
| Sept 1998 | - | $14.30 M(+116.7%) |
| June 1998 | - | $6.60 M(-14.3%) |
| Mar 1998 | - | $7.70 M(-14.4%) |
| Dec 1997 | $9.00 M(+69.8%) | $9.00 M(+400.0%) |
| Sept 1997 | - | $1.80 M(-35.7%) |
| June 1997 | - | $2.80 M(-30.0%) |
| Mar 1997 | - | $4.00 M(-24.5%) |
| Dec 1996 | $5.30 M(-53.1%) | $5.30 M(-19.7%) |
| Sept 1996 | - | $6.60 M(+164.0%) |
| June 1996 | - | $2.50 M(-30.6%) |
| Mar 1996 | - | $3.60 M(-68.1%) |
| Dec 1995 | $11.30 M | $11.30 M |
FAQ
- What is AIM ImmunoTech annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for AIM ImmunoTech?
- What is AIM ImmunoTech quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for AIM ImmunoTech?
- What is AIM ImmunoTech quarterly cash and cash equivalents year-on-year change?
What is AIM ImmunoTech annual cash & cash equivalents?
The current annual cash & cash equivalents of AIM is $5.44 M
What is the all time high annual cash & cash equivalents for AIM ImmunoTech?
AIM ImmunoTech all-time high annual cash & cash equivalents is $58.07 M
What is AIM ImmunoTech quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AIM is $915.00 K
What is the all time high quarterly cash and cash equivalents for AIM ImmunoTech?
AIM ImmunoTech all-time high quarterly cash and cash equivalents is $61.04 M
What is AIM ImmunoTech quarterly cash and cash equivalents year-on-year change?
Over the past year, AIM quarterly cash and cash equivalents has changed by -$4.52 M (-83.18%)